(5R)-5-methyl-2-piperazinone hydrochloride
|
- $170 - $468
- Product name: (5R)-5-methyl-2-piperazinone hydrochloride
- CAS: 1609388-52-4
- MF: C5H11ClN2O
- MW: 150.61
- EINECS:
- MDL Number:MFCD26937638
- Synonyms:(5R)-5-methyl-2-piperazinone hydrochloride;(R)-5-methyl-2-piperazinone hydrochloride;(R)-5-Methylpiperazin-2-one Hydrochloride;2-Piperazinone, 5-methyl-, hydrochloride (1:1), (5R)- - [AC77928]
4 prices
Selected condition:
Brand
- ChemBridge Corporation
- Crysdot
Package
- 250mg
- 1g
- ManufacturerChemBridge Corporation
- Product numberBB-4082079
- Product description(5R)-5-methyl-2-piperazinonehydrochloride 95%
- Packaging1g
- Price$300
- Updated2021-12-16
- Buy
- ManufacturerChemBridge Corporation
- Product numberBB-4082079
- Product description(5R)-5-methyl-2-piperazinonehydrochloride 95%
- Packaging250mg
- Price$170
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11244532
- Product description(R)-5-Methylpiperazin-2-onehydrochloride 97%
- Packaging250mg
- Price$299
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11244532
- Product description(R)-5-Methylpiperazin-2-onehydrochloride 97%
- Packaging1g
- Price$468
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| ChemBridge Corporation | BB-4082079 | (5R)-5-methyl-2-piperazinonehydrochloride 95% | 1g | $300 | 2021-12-16 | Buy |
| ChemBridge Corporation | BB-4082079 | (5R)-5-methyl-2-piperazinonehydrochloride 95% | 250mg | $170 | 2021-12-16 | Buy |
| Crysdot | CD11244532 | (R)-5-Methylpiperazin-2-onehydrochloride 97% | 250mg | $299 | 2021-12-16 | Buy |
| Crysdot | CD11244532 | (R)-5-Methylpiperazin-2-onehydrochloride 97% | 1g | $468 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|




